annual EBIT:
$5.30B-$3.15B(-37.28%)Summary
- As of today (May 20, 2025), GSK annual earnings before interest & taxes is $5.30 billion, with the most recent change of -$3.15 billion (-37.28%) on December 31, 2024.
- During the last 3 years, GSK annual EBIT has fallen by -$703.62 million (-11.72%).
- GSK annual EBIT is now -69.21% below its all-time high of $17.21 billion, reached on December 31, 2015.
Performance
GSK EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$2.86B+$1.95B(+215.76%)Summary
- As of today (May 20, 2025), GSK quarterly earnings before interest & taxes is $2.86 billion, with the most recent change of +$1.95 billion (+215.76%) on March 31, 2025.
- Over the past year, GSK quarterly EBIT has increased by +$929.02 million (+48.16%).
- GSK quarterly EBIT is now -81.36% below its all-time high of $15.33 billion, reached on March 31, 2015.
Performance
GSK quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$6.16B+$929.02M(+17.78%)Summary
- As of today (May 20, 2025), GSK TTM earnings before interest & taxes is $6.16 billion, with the most recent change of +$929.02 million (+17.78%) on March 31, 2025.
- Over the past year, GSK TTM EBIT has dropped by -$1.65 billion (-21.18%).
- GSK TTM EBIT is now -68.60% below its all-time high of $19.60 billion, reached on March 31, 2015.
Performance
GSK TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
GSK EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.3% | +48.2% | -21.2% |
| 3 y3 years | -11.7% | -7.3% | -16.9% |
| 5 y5 years | -41.5% | +8.0% | -36.6% |
GSK EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -37.3% | at low | -7.3% | +898.5% | -38.1% | +23.5% |
| 5 y | 5-year | -41.5% | at low | -19.7% | +376.7% | -45.7% | +23.5% |
| alltime | all time | -69.2% | >+9999.0% | -81.4% | +132.1% | -68.6% | >+9999.0% |
GSK EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $2.86B(+215.8%) | $6.16B(+17.8%) |
| Dec 2024 | $5.30B(-37.3%) | $905.19M(+216.2%) | $5.23B(+4.9%) |
| Sep 2024 | - | $286.27M(-86.4%) | $4.98B(-30.7%) |
| Jun 2024 | - | $2.11B(+9.2%) | $7.20B(-7.8%) |
| Mar 2024 | - | $1.93B(+190.9%) | $7.81B(-7.5%) |
| Dec 2023 | $8.45B(+5.7%) | $663.21M(-73.5%) | $8.44B(-15.1%) |
| Sep 2023 | - | $2.50B(-8.1%) | $9.95B(+12.1%) |
| Jun 2023 | - | $2.72B(+6.0%) | $8.88B(+17.7%) |
| Mar 2023 | - | $2.56B(+18.3%) | $7.54B(-6.4%) |
| Dec 2022 | $7.99B(+33.2%) | $2.17B(+51.9%) | $8.06B(+23.1%) |
| Sep 2022 | - | $1.43B(+3.1%) | $6.55B(-6.9%) |
| Jun 2022 | - | $1.38B(-55.2%) | $7.03B(-5.1%) |
| Mar 2022 | - | $3.08B(+371.8%) | $7.41B(+10.7%) |
| Dec 2021 | $6.00B(-22.3%) | $653.80M(-65.8%) | $6.70B(+33.7%) |
| Sep 2021 | - | $1.91B(+8.7%) | $5.01B(-9.1%) |
| Jun 2021 | - | $1.76B(-25.7%) | $5.51B(-24.6%) |
| Mar 2021 | - | $2.37B(-329.4%) | $7.31B(-3.6%) |
| Dec 2020 | $7.72B(-14.8%) | -$1.03B(-142.8%) | $7.59B(-31.3%) |
| Sep 2020 | - | $2.42B(-32.1%) | $11.05B(-2.6%) |
| Jun 2020 | - | $3.56B(+34.5%) | $11.34B(+16.8%) |
| Mar 2020 | - | $2.65B(+9.0%) | $9.71B(+7.4%) |
| Dec 2019 | $9.07B(+23.7%) | $2.43B(-10.3%) | $9.04B(+6.2%) |
| Sep 2019 | - | $2.71B(+40.3%) | $8.52B(+2.2%) |
| Jun 2019 | - | $1.93B(-2.5%) | $8.34B(+11.0%) |
| Mar 2019 | - | $1.98B(+4.0%) | $7.51B(+2.9%) |
| Dec 2018 | $7.33B(+33.2%) | $1.90B(-24.6%) | $7.29B(+17.9%) |
| Sep 2018 | - | $2.52B(+129.3%) | $6.19B(+0.5%) |
| Jun 2018 | - | $1.10B(-37.6%) | $6.15B(+21.4%) |
| Mar 2018 | - | $1.76B(+121.8%) | $5.07B(-7.2%) |
| Dec 2017 | $5.50B(+52.9%) | $795.42M(-68.1%) | $5.47B(+1.0%) |
| Sep 2017 | - | $2.49B(>+9900.0%) | $5.41B(+12.1%) |
| Jun 2017 | - | $17.90M(-99.2%) | $4.83B(+4.6%) |
| Mar 2017 | - | $2.16B(+191.3%) | $4.62B(+31.3%) |
| Dec 2016 | $3.60B(-79.1%) | $741.57M(-61.1%) | $3.52B(+45.8%) |
| Sep 2016 | - | $1.91B(-1084.2%) | $2.41B(+14.0%) |
| Jun 2016 | - | -$193.92M(-118.3%) | $2.12B(-25.5%) |
| Mar 2016 | - | $1.06B(-392.6%) | $2.84B(-83.4%) |
| Dec 2015 | $17.21B(+184.4%) | -$362.52M(-122.5%) | $17.11B(-7.9%) |
| Sep 2015 | - | $1.61B(+204.1%) | $18.57B(+2.2%) |
| Jun 2015 | - | $529.98M(-96.5%) | $18.18B(-7.3%) |
| Mar 2015 | - | $15.33B(+1292.3%) | $19.60B(+223.1%) |
| Dec 2014 | $6.05B(-47.6%) | $1.10B(-9.3%) | $6.07B(-35.0%) |
| Sep 2014 | - | $1.21B(-38.0%) | $9.33B(-11.9%) |
| Jun 2014 | - | $1.96B(+9.0%) | $10.58B(-3.0%) |
| Mar 2014 | - | $1.80B(-58.8%) | $10.91B(-6.1%) |
| Dec 2013 | $11.56B(-0.9%) | $4.36B(+76.6%) | $11.62B(+12.7%) |
| Sep 2013 | - | $2.47B(+8.3%) | $10.31B(-1.8%) |
| Jun 2013 | - | $2.28B(-9.0%) | $10.50B(-4.0%) |
| Mar 2013 | - | $2.51B(-18.0%) | $10.95B(-6.1%) |
| Dec 2012 | $11.66B(-14.0%) | $3.06B(+14.9%) | $11.66B(+1.1%) |
| Sep 2012 | - | $2.66B(-2.3%) | $11.53B(-6.3%) |
| Jun 2012 | - | $2.72B(-15.5%) | $12.30B(-1.7%) |
| Mar 2012 | - | $3.22B(+10.2%) | $12.52B(-7.6%) |
| Dec 2011 | $13.56B(+123.1%) | $2.93B(-14.8%) | $13.56B(+33.1%) |
| Sep 2011 | - | $3.43B(+16.7%) | $10.19B(+3.5%) |
| Jun 2011 | - | $2.94B(-30.9%) | $9.84B(+39.8%) |
| Mar 2011 | - | $4.26B(-1055.5%) | $7.04B(+15.1%) |
| Dec 2010 | $6.08B(-55.3%) | -$445.46M(-114.4%) | $6.11B(-42.2%) |
| Sep 2010 | - | $3.09B(+2154.6%) | $10.58B(-3.4%) |
| Jun 2010 | - | $137.14M(-95.9%) | $10.96B(-23.3%) |
| Mar 2010 | - | $3.33B(-17.2%) | $14.28B(+4.7%) |
| Dec 2009 | $13.59B(-2.1%) | $4.02B(+16.1%) | $13.64B(+12.0%) |
| Sep 2009 | - | $3.46B(-0.0%) | $12.18B(+1.0%) |
| Jun 2009 | - | $3.46B(+29.0%) | $12.06B(-4.6%) |
| Mar 2009 | - | $2.69B(+4.9%) | $12.64B(-9.7%) |
| Dec 2008 | $13.87B(-15.5%) | $2.56B(-23.5%) | $13.99B(-12.1%) |
| Sep 2008 | - | $3.35B(-17.2%) | $15.92B(+25.6%) |
| Jun 2008 | - | $4.04B(+0.0%) | $12.68B(+0.3%) |
| Mar 2008 | - | $4.04B(-9.9%) | $12.64B(-2.6%) |
| Dec 2007 | $16.41B(+14.0%) | $4.49B(+4185.0%) | $12.97B(+15.2%) |
| Sep 2007 | - | $104.74M(-97.4%) | $11.27B(-26.9%) |
| Jun 2007 | - | $4.01B(-8.5%) | $15.42B(+3.4%) |
| Mar 2007 | - | $4.38B(+57.4%) | $14.91B(+4.0%) |
| Dec 2006 | $14.39B(+2074.0%) | $2.78B(-34.6%) | $14.34B(+438.2%) |
| Sep 2006 | - | $4.25B(+21.7%) | $2.66B(+34.6%) |
| Jun 2006 | - | $3.50B(-8.2%) | $1.98B(+19.7%) |
| Mar 2006 | - | $3.81B(-142.8%) | $1.65B(+40.7%) |
| Dec 2005 | $661.92M(-93.7%) | -$8.89B(-349.1%) | $1.17B(-90.5%) |
| Sep 2005 | - | $3.57B(+12.6%) | $12.38B(+7.3%) |
| Jun 2005 | - | $3.17B(-4.7%) | $11.53B(+1.1%) |
| Mar 2005 | - | $3.33B(+44.0%) | $11.40B(+5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2004 | $10.54B(+1.0%) | $2.31B(-15.2%) | $10.84B(+4.7%) |
| Sep 2004 | - | $2.72B(-10.4%) | $10.36B(+0.0%) |
| Jun 2004 | - | $3.04B(+9.8%) | $10.36B(-0.7%) |
| Mar 2004 | - | $2.77B(+51.4%) | $10.43B(+0.4%) |
| Dec 2003 | $10.44B(+21.6%) | $1.83B(-32.8%) | $10.39B(-3.9%) |
| Sep 2003 | - | $2.72B(-12.7%) | $10.82B(+9.5%) |
| Jun 2003 | - | $3.12B(+14.3%) | $9.88B(+7.5%) |
| Mar 2003 | - | $2.72B(+20.9%) | $9.19B(+7.4%) |
| Dec 2002 | $8.58B(-2.4%) | $2.25B(+26.3%) | $8.56B(-17.8%) |
| Sep 2002 | - | $1.78B(-26.6%) | $10.42B(+7.8%) |
| Jun 2002 | - | $2.43B(+16.4%) | $9.66B(+3.6%) |
| Mar 2002 | - | $2.09B(-49.2%) | $9.32B(+6.1%) |
| Dec 2001 | $8.79B(-8.6%) | $4.11B(+299.0%) | $8.79B(+1.7%) |
| Sep 2001 | - | $1.03B(-50.7%) | $8.64B(-6.8%) |
| Jun 2001 | - | $2.09B(+34.9%) | $9.27B(+0.9%) |
| Mar 2001 | - | $1.55B(-60.9%) | $9.18B(-3.5%) |
| Dec 2000 | $9.62B(+113.7%) | $3.97B(+138.9%) | $9.52B(<-9900.0%) |
| Sep 2000 | - | $1.66B(-17.2%) | -$41.95M(-102.2%) |
| Jun 2000 | - | $2.00B(+6.4%) | $1.94B(+88.5%) |
| Mar 2000 | - | $1.88B(-133.7%) | $1.03B(-57.6%) |
| Dec 1999 | $4.50B(-5.5%) | -$5.59B(-253.4%) | $2.43B(-16.7%) |
| Sep 1999 | - | $3.65B(+233.8%) | $2.92B(+9.2%) |
| Jun 1999 | - | $1.09B(-66.8%) | $2.67B(+3.1%) |
| Mar 1999 | - | $3.29B(-164.4%) | $2.59B(+4.3%) |
| Dec 1998 | $4.76B(-0.2%) | -$5.11B(-250.1%) | $2.49B(+11.3%) |
| Sep 1998 | - | $3.40B(+236.4%) | $2.23B(+7.0%) |
| Jun 1998 | - | $1.01B(-68.2%) | $2.09B(-52.2%) |
| Mar 1998 | - | $3.18B(-159.3%) | $4.37B(-3.5%) |
| Dec 1997 | $4.77B(-5.7%) | -$5.36B(-264.7%) | $4.53B(-35.7%) |
| Sep 1997 | - | $3.25B(-1.1%) | $7.04B(-8.0%) |
| Jun 1997 | - | $3.29B(-1.4%) | $7.65B(+1.4%) |
| Mar 1997 | - | $3.34B(-217.3%) | $7.55B(+1.1%) |
| Dec 1996 | $5.06B(+17.7%) | -$2.85B(-173.6%) | $7.47B(-27.6%) |
| Sep 1996 | - | $3.87B(+21.3%) | $10.31B(+14.5%) |
| Jun 1996 | - | $3.19B(-2.1%) | $9.01B(+1745.6%) |
| Mar 1996 | - | $3.26B(+27.0%) | $488.17M(-79.4%) |
| Dec 1995 | $4.30B(+87.4%) | - | - |
| Sep 1995 | - | $2.56B(-148.1%) | $2.37B(+1.4%) |
| Jun 1995 | - | -$5.33B(-310.9%) | $2.34B(-41.0%) |
| Jun 1995 | $2.29B(-18.4%) | - | - |
| Mar 1995 | - | $2.53B(-3.3%) | $3.97B(+7.2%) |
| Dec 1994 | - | $2.61B(+3.3%) | $3.70B(+15.4%) |
| Sep 1994 | - | $2.53B(-168.3%) | $3.21B(+15.8%) |
| Jun 1994 | $2.81B(-0.0%) | -$3.71B(-263.9%) | $2.77B(-14.6%) |
| Mar 1994 | - | $2.26B(+6.6%) | $3.24B(+1.0%) |
| Dec 1993 | - | $2.12B(+1.3%) | $3.21B(+10.8%) |
| Sep 1993 | - | $2.09B(-164.8%) | $2.90B(+8.7%) |
| Jun 1993 | $2.81B(+7.3%) | -$3.23B(-245.0%) | $2.66B(+5.8%) |
| Mar 1993 | - | $2.23B(+23.3%) | $2.52B(+10.9%) |
| Dec 1992 | - | $1.81B(-2.9%) | $2.27B(-1.8%) |
| Sep 1992 | - | $1.86B(-155.1%) | $2.31B(-0.5%) |
| Jun 1992 | $2.62B(+4.0%) | -$3.38B(-270.5%) | $2.33B(-41.3%) |
| Mar 1992 | - | $1.98B(+7.2%) | $3.96B(+13.4%) |
| Dec 1991 | - | $1.85B(-1.3%) | $3.49B(+15.1%) |
| Sep 1991 | - | $1.87B(-207.3%) | $3.03B(+19.9%) |
| Jun 1991 | $2.52B(+26.3%) | -$1.75B(-215.4%) | $2.53B(-0.9%) |
| Mar 1991 | - | $1.51B(+8.7%) | $2.55B(+9.2%) |
| Dec 1990 | - | $1.39B(+1.5%) | $2.34B(+9.3%) |
| Sep 1990 | - | $1.37B(-179.5%) | $2.14B(+9.4%) |
| Jun 1990 | $2.00B(+12.7%) | -$1.72B(-232.7%) | $1.96B(-20.5%) |
| Mar 1990 | - | $1.30B(+8.8%) | $2.46B(+12.8%) |
| Dec 1989 | - | $1.19B(+0.5%) | $2.18B(+9.3%) |
| Sep 1989 | - | $1.19B(-197.3%) | $1.99B(+9.3%) |
| Jun 1989 | $1.77B(+18.4%) | -$1.22B(-219.8%) | $1.82B(-9.2%) |
| Mar 1989 | - | $1.02B(+1.1%) | $2.01B(+8.3%) |
| Dec 1988 | - | $1.01B(-1.1%) | $1.85B(+11.6%) |
| Sep 1988 | - | $1.02B(-198.4%) | $1.66B(+10.4%) |
| Jun 1988 | $1.50B(+29.6%) | -$1.03B(-219.8%) | $1.51B(-10.5%) |
| Mar 1988 | - | $863.72M(+6.1%) | $1.68B(+9.7%) |
| Dec 1987 | - | $814.42M(-5.5%) | $1.53B(+13.5%) |
| Sep 1987 | - | $862.23M(-200.4%) | $1.35B(+16.3%) |
| Jun 1987 | $1.15B(+29.5%) | -$858.44M(-220.2%) | $1.16B(-7.3%) |
| Mar 1987 | - | $714.30M(+12.9%) | $1.25B(+15.9%) |
| Dec 1986 | - | $632.59M(-6.0%) | $1.08B(+8.4%) |
| Sep 1986 | - | $672.76M(-187.7%) | $995.94M(+15.3%) |
| Jun 1986 | $891.48M(>+9900.0%) | -$767.31M(-241.6%) | $863.62M(-47.0%) |
| Mar 1986 | - | $542.04M(-1.2%) | $1.63B(+49.8%) |
| Dec 1985 | - | $548.45M(+1.5%) | $1.09B(+101.5%) |
| Sep 1985 | - | $540.44M | $540.44M |
| Jun 1985 | $0.00(0.0%) | - | - |
| Jun 1984 | $0.00 | - | - |
FAQ
- What is GSK annual earnings before interest & taxes?
- What is the all time high annual EBIT for GSK?
- What is GSK annual EBIT year-on-year change?
- What is GSK quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for GSK?
- What is GSK quarterly EBIT year-on-year change?
- What is GSK TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for GSK?
- What is GSK TTM EBIT year-on-year change?
What is GSK annual earnings before interest & taxes?
The current annual EBIT of GSK is $5.30B
What is the all time high annual EBIT for GSK?
GSK all-time high annual earnings before interest & taxes is $17.21B
What is GSK annual EBIT year-on-year change?
Over the past year, GSK annual earnings before interest & taxes has changed by -$3.15B (-37.28%)
What is GSK quarterly earnings before interest & taxes?
The current quarterly EBIT of GSK is $2.86B
What is the all time high quarterly EBIT for GSK?
GSK all-time high quarterly earnings before interest & taxes is $15.33B
What is GSK quarterly EBIT year-on-year change?
Over the past year, GSK quarterly earnings before interest & taxes has changed by +$929.02M (+48.16%)
What is GSK TTM earnings before interest & taxes?
The current TTM EBIT of GSK is $6.16B
What is the all time high TTM EBIT for GSK?
GSK all-time high TTM earnings before interest & taxes is $19.60B
What is GSK TTM EBIT year-on-year change?
Over the past year, GSK TTM earnings before interest & taxes has changed by -$1.65B (-21.18%)